Recent Advances In Surveillance of Patients With Barrett’s Esophagus

Barrett’s esophagus (BE), the precursor lesion and the most important risk factor for esophageal adenocarcinoma (EAC), has an estimated prevalence of 5.6% in the adult US population.¹

Compared with the general population, patients with BE are 30 to 125 times more likely to develop EAC, with an annual incidence of 0.2% to 0.4%.² EAC,